Aurobindo Pharma Limited — Updates, 22-06-2026: Press Release
22-06-2026 | 07:31 am
22-06-2026 | 07:31 am
Aurobindo Pharma USA received necessary approvals to acquire Lannett Company for $250 million. This expands product offerings, adds a US manufacturing facility, and is expected to be immediately accretive to EPS, driving future growth.
No comments yet. Be the first to comment!
